Dr. Pasi Janne gives an update on the research lead by the Lung Cancer Dream Team, which was created and funded by a partnership between Stand Up For Cancer and The American Cancer Society.
Craig Crews's recent study demonstrates the use of PROTAC technology to target difficult-to-treat oncoproteins such as mutant forms of BRAF. Learn more.
In the pilot program during summer 2021, 8 universities kicked off the American Cancer Society (ACS) Diversity in Cancer Research (DICR) internships. For summer 2022, 12 universities will have ACS DICR interns.